Latest Prescription Drugs news
Pfizer Recalls All Lots of Chantix Due to Potential Carcinogen
posted September 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
Most With AD, MCI Would Have Been Excluded From Aducanumab Clinical Trials
posted September 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Government Buys More Monoclonal Antibody Treatments to Ward Off Shortage
posted September 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Isotretinoin Does Not Up Suicide Risk in Acne Patients
posted September 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
